The drug resistance criteria include no significant decline in β-HCG after 2 therapeutic courses (not exceeding 1/10), stable β-HCG levels or an increasing trend in β-HCG levels.
← all excerpts
Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm.
1
—
—